PDC*line Pharma

Location

liège

Region

wallonia

Stage

scaleup

Founded

2014

Status

active

Website

pdc-line-pharma.com

Sector

biotech, medtech, immunotherapy

TLDR

PDC*line Pharma develops off-the-shelf cancer immunotherapy targeting lung cancer and neoantigens.

Overview

PDC*line Pharma is an innovative Belgian-French biotechnology company founded in April 2014 as a spin-off of the Établissement Français du Sang (EFS), dedicated to developing antigen-specific cancer immunotherapies. The company operates research and development centers in Liège, Belgium and Grenoble, France.

Filed under

companies liège biotech medtech immunotherapy